use of arka tail and manshiladi lepa in eczema

A Randomized Comparative Trial on the efficacy of Arka Tail and Manashiladi Lepa in the management of vicharchika (SN43) (eczema). - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098851

Enrollment

140

Registered

2025-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patient of vicharchika according to subjective perameter of samhitas has complaints of itching, Burning sensation,discharge, dryness, eruption, and depigmentation

Exclusion criteria

Exclusion criteria: 1. Patients suffering from disorders like diabetes Mellitus, systemic infections. 2. Age- below 12 years and above 60 years. 3. patients who are suffering from major psychiatric disorders. 4. Patients suffering from major systemic illnesses like myocardial infraction, Ischemic heart disease, AIDS, Cancer, Major respiratory disease, liver failure, Renal failure and Renal toxicity etc.

Design outcomes

Primary

Measure	Time frame
Any changes in EASI scoreTimepoint: 90 days	—

Secondary

Measure	Time frame
Arka Tail and Manashiladi Lepa will provide a safe and effective treatment and improve the quality of lifeTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Rameshwar lal

PGIA JODHPUR

vddschahar1973@gmail.com9636981669

Outcome results